688238 和元生物
已收盘 11-14 15:00:01
资讯
新帖
简况
和元生物:11月13日召开业绩说明会,投资者参与
证券之星 · 11-13 20:34
和元生物:11月13日召开业绩说明会,投资者参与
和元生物11月12日遭主力抛售1927万元 环比增加9535.00%
市场透视 · 11-12 15:21
和元生物11月12日遭主力抛售1927万元 环比增加9535.00%
和元生物创6个月新高 1家券商给予增持建议
智选洞察 · 11-11
和元生物创6个月新高 1家券商给予增持建议
和元生物创1个月新高 获融资净买入543万元
智选洞察 · 11-08
和元生物创1个月新高 获融资净买入543万元
和元生物11月04日主力资金流入867万元 连续3日加仓
市场透视 · 11-04
和元生物11月04日主力资金流入867万元 连续3日加仓
和元生物大幅上涨 获主力净流入114万元
智选洞察 · 11-01
和元生物大幅上涨 获主力净流入114万元
和元生物10月30日主力资金流出982万元 连续3日减仓
市场透视 · 10-30
和元生物10月30日主力资金流出982万元 连续3日减仓
CGT赛道前景不明,和元生物扭亏之路坎坷?︱财报点评
第一财经 · 10-25
CGT赛道前景不明,和元生物扭亏之路坎坷?︱财报点评
图解和元生物三季报:第三季度单季净利润同比减190.56%
证券之星 · 10-24
图解和元生物三季报:第三季度单季净利润同比减190.56%
和元生物:业绩说明会定于11月13日举行
每日经济新闻 · 10-23
和元生物:业绩说明会定于11月13日举行
和元生物:2024年前三季度净利润约-1.90亿元
每日经济新闻 · 10-23
和元生物:2024年前三季度净利润约-1.90亿元
和元生物(688238.SH)发前三季业绩,净亏损1.9亿元
智通财经 · 10-23
和元生物(688238.SH)发前三季业绩,净亏损1.9亿元
和元生物(688238)10月21日主力资金净买入560.37万元
证券之星 · 10-22
和元生物(688238)10月21日主力资金净买入560.37万元
和元生物大幅上涨 获主力净流入62万元
智选洞察 · 10-21
和元生物大幅上涨 获主力净流入62万元
和元生物大幅上涨 众安保险百万医疗险升级
智选洞察 · 10-18
和元生物大幅上涨 众安保险百万医疗险升级
和元生物大跌5.04% 获主力净流出757万元
智选洞察 · 10-11
和元生物大跌5.04% 获主力净流出757万元
和元生物(688238)10月10日主力资金净卖出818.05万元
证券之星 · 10-11
和元生物(688238)10月10日主力资金净卖出818.05万元
和元生物10月10日主力资金流出827万元 连续7日减仓
市场透视 · 10-10
和元生物10月10日主力资金流出827万元 连续7日减仓
和元生物大跌5.48% 融资融券余额实现2连增
智选洞察 · 10-09
和元生物大跌5.48% 融资融券余额实现2连增
和元生物创4个月新高 获融资净买入9万元
智选洞察 · 10-08
和元生物创4个月新高 获融资净买入9万元
公司概况
公司名称:
和元生物技术(上海)股份有限公司
所属行业:
研究和试验发展
上市日期:
2022-03-22
主营业务:
和元生物技术(上海)股份有限公司是一家聚焦基因治疗领域的生物科技公司,专注于为基因治疗的基础研究提供基因治疗载体研制、基因功能研究等CRO服务,以及为基因药物的研发提供IND-CMC药学研究、临床样品GMP生产等CDMO服务。主要产品有基因治疗CRO、基因治疗CDMO、生物制剂、试剂。
发行价格:
13.23
{"stockData":{"symbol":"688238","market":"SH","secType":"STK","nameCN":"和元生物","latestPrice":6.06,"timestamp":1731567601000,"preClose":6.34,"halted":0,"volume":13449333,"delay":0,"floatShares":467000000,"shares":647000000,"eps":-0.3809,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.28,"latestTime":"11-14 15:00:01","open":6.45,"high":6.48,"low":6.03,"amount":83435500,"amplitude":0.071,"askPrice":6.07,"askSize":30,"bidPrice":6.06,"bidSize":24,"shortable":0,"etf":0,"ttmEps":-0.3809,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731634200000},"adr":0,"adjPreClose":6.34,"symbolType":"stock_kcb","openAndCloseTimeList":[[1731547800000,1731555000000],[1731560400000,1731567600000]],"highLimit":6.97,"lowLimit":5.71,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":647433100,"pbRate":2.1,"roa":"--","roe":"--","epsLYR":-0.199,"committee":0.494832,"marketValue":3923000000,"floatMarketCap":2828000000,"peRate":-15.909688,"changeRate":-0.0442,"turnoverRate":0.0288,"status":1,"afterMarket":{"amount":0,"volume":0,"close":6.06,"buyVolume":0,"sellVolume":0,"time":1731569639464,"indexStatus":"已收盘 11-14 15:30:00","preClose":6.34}},"requestUrl":"/m/hq/s/688238/wiki","defaultTab":"wiki","newsList":[{"id":"2483187004","title":"和元生物:11月13日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2483187004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483187004?lang=zh_cn&edition=full","pubTime":"2024-11-13 20:34","pubTimestamp":1731501281,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月13日和元生物发布公告称公司于2024年11月13日召开业绩说明会。和元生物2024年三季报显示,公司主营收入1.84亿元,同比上升34.22%;归母净利润-1.9亿元,同比下降166.9%;扣非净利润-2.0亿元,同比下降155.03%;其中2024年第三季度,公司单季度主营收入7080.58万元,同比上升32.99%;单季度归母净利润-7642.14万元,同比下降190.56%;单季度扣非净利润-8094.48万元,同比下降156.81%;负债率20.62%,投资收益-130.17万元,财务费用27.9万元,毛利率-21.95%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300034440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2482726042","title":"和元生物11月12日遭主力抛售1927万元 环比增加9535.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482726042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482726042?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:21","pubTimestamp":1731396079,"startTime":"0","endTime":"0","summary":"11月12日, 和元生物股价跌2.13%,报收6.43元,成交金额1.76亿元,换手率5.70%,振幅6.70%,量比1.22。和元生物今日主力资金净流出1927万元,上一交易日主力净流出20万元,今日环比增加9535.00%。该股近5个交易日上涨10.86%,主力资金累计净流出2553万元;近20日主力资金累计净流出2644万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112154910a22f8754&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112154910a22f8754&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2482735243","title":"和元生物创6个月新高 1家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2482735243","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482735243?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:40","pubTimestamp":1731289257,"startTime":"0","endTime":"0","summary":"11月11日,和元生物股价大幅上涨,截至09点40分,和元生物上涨5.62%,报6.58元/股,创近6个月新高,成交3054万元,换手率1.03%,振幅6.26%。此外,数据统计显示,近半年内1家券商给予增持建议,1家券商给予买入建议。资金动向截止发稿,和元生物获得主力净流出11万元,其中超大单流入18万元,大单流出28万元。最新财报显示,今年三季报,和元生物实现营业收入1.84亿元,同比增长34.22%,净利润为-1.90亿元,同比减少166.90%,基本每股收益为-0.29元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111100834abb455fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111100834abb455fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2481169703","title":"和元生物创1个月新高 获融资净买入543万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481169703","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481169703?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:33","pubTimestamp":1731029586,"startTime":"0","endTime":"0","summary":"11月08日,和元生物股价大幅上涨,截至09点33分,和元生物上涨5.08%,报6.20元/股,创近1个月新高,成交1213万元,换手率0.42%。资金动向截止发稿,和元生物获得主力净流入105万元,其中超大单流出184万元,大单流入290万元。数据显示,该股今日净流入较近5日净流入均值减少86万元。融资融券方面,和元生物11月06日获得融资净买入543万元,当日该股融资余额为1.73亿元,当较前一日增加3.24%;该股融券余额为18万元,融券余量为2.95万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108093744ababa875&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108093744ababa875&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2480322717","title":"和元生物11月04日主力资金流入867万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2480322717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480322717?lang=zh_cn&edition=full","pubTime":"2024-11-04 15:18","pubTimestamp":1730704722,"startTime":"0","endTime":"0","summary":"11月04日, 和元生物股价涨2.75%,报收5.60元,成交金额7064万元,换手率2.71%,振幅5.50%,量比0.86。和元生物今日主力资金净流入867万元,连续3日净流入,上一交易日主力净流入1292万元,今日环比减少32.89%。|11月04日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|汇金科技|5.81%|#|硕贝德|5.15%|#|星网宇达|4.83%|#|安乃达|4.50%|#|铭科精技|4.16%|#|延华智能|3.91%|#|惠天热电|3.87%|#|常山北明|3.73%|#|新力金融|3.61%|#|南方精工|3.27%|和元生物所在的医疗服务行业,今日主力净流入2.89亿元,行业排名25/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104153043a2140293&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104153043a2140293&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2480019083","title":"和元生物大幅上涨 获主力净流入114万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480019083","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480019083?lang=zh_cn&edition=full","pubTime":"2024-11-01 09:37","pubTimestamp":1730425050,"startTime":"0","endTime":"0","summary":"11月01日,和元生物股价大幅上涨,截至09点37分,和元生物上涨5.41%,报5.65元/股,成交1416万元,换手率0.55%,振幅5.41%。资金动向截止发稿,和元生物获得主力净流入114万元,其中超大单流入167万元,大单流出53万元。数据显示,该股今日净流入较近5日净流入均值增加599万元。最新财报显示,今年三季报,和元生物实现营业收入1.84亿元,同比增长34.22%,净利润为-1.90亿元,同比减少166.90%,基本每股收益为-0.29元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101093843a2054910&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101093843a2054910&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2479170223","title":"和元生物10月30日主力资金流出982万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2479170223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479170223?lang=zh_cn&edition=full","pubTime":"2024-10-30 15:19","pubTimestamp":1730272777,"startTime":"0","endTime":"0","summary":"10月30日, 和元生物股价跌2.24%,报收5.23元,成交金额5926万元,换手率2.42%,振幅3.74%,量比0.80。和元生物今日主力资金净流出982万元,连续3日净流出,上一交易日主力净流出1113万元,今日环比减少11.77%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为46.15%,平均跌幅为2.21%。该股近5个交易日上涨0.19%,主力资金累计净流出2904万元;近20日主力资金累计净流出8311万元,其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030154039ab82342a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030154039ab82342a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2478459586","title":"CGT赛道前景不明,和元生物扭亏之路坎坷?︱财报点评","url":"https://stock-news.laohu8.com/highlight/detail?id=2478459586","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478459586?lang=zh_cn&edition=full","pubTime":"2024-10-25 09:48","pubTimestamp":1729820926,"startTime":"0","endTime":"0","summary":"截至今年8月8日,全球CGT领域共发生融资16笔,融资金额仅为5亿美元。和元生物在2022年上市时恰逢CGT行业景气高峰,公司营收也在2020-2022年不断创下新高,2023年以来该公司的营收规模开始下降,业绩再度转为亏损。如今在行业前景不明朗,资本持续谨慎的大背景下,相关CGT临床项目有多少能够最终推进到上市生产,又能为企业带来多大的订单需求,这都存在着巨大的不确定性,和元生物的扭亏之路仍然面临挑战。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025094947ab71dfe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025094947ab71dfe0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238"],"gpt_icon":0},{"id":"2477559036","title":"图解和元生物三季报:第三季度单季净利润同比减190.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477559036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477559036?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:35","pubTimestamp":1729701315,"startTime":"0","endTime":"0","summary":"证券之星消息,和元生物2024年三季报显示,公司主营收入1.84亿元,同比上升34.22%;归母净利润-1.9亿元,同比下降166.9%;扣非净利润-2.0亿元,同比下降155.03%;其中2024年第三季度,公司单季度主营收入7080.58万元,同比上升32.99%;单季度归母净利润-7642.14万元,同比下降190.56%;单季度扣非净利润-8094.48万元,同比下降156.81%;负债率20.62%,投资收益-130.17万元,财务费用27.9万元,毛利率-21.95%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400000234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238"],"gpt_icon":0},{"id":"2477304580","title":"和元生物:业绩说明会定于11月13日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2477304580","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477304580?lang=zh_cn&edition=full","pubTime":"2024-10-23 18:03","pubTimestamp":1729677787,"startTime":"0","endTime":"0","summary":"每经AI快讯,和元生物 10月23日晚间发布公告称,公司2024年第三季度业绩说明会定于2024年11月13日下午16:00-17:00,以上证路演中心网络互动的形式进行。出席本次业绩说明会的人员有:董事长、总经理潘讴东,副总经理、财务负责人、董事会秘书徐鲁媛,独立董事宋正奇。2023年1至12月份,和元生物的营业收入构成为:生物医药占比99.63%。截至发稿,和元生物市值为34亿元。道达号“个股趋势”提醒:1. 近30日内无机构对和元生物进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023180504ab6cedb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023180504ab6cedb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2477538304","title":"和元生物:2024年前三季度净利润约-1.90亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477538304","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477538304?lang=zh_cn&edition=full","pubTime":"2024-10-23 18:02","pubTimestamp":1729677767,"startTime":"0","endTime":"0","summary":"每经AI快讯,和元生物(SH 688238,收盘价:5.22元)10月23日晚间发布三季度业绩公告称,2024年前三季度营收约1.84亿元,同比增加34.22%;归属于上市公司股东的净利润亏损约1.9亿元;基本每股收益亏损0.293元。截至发稿,和元生物市值为34亿元。道达号(daoda1997)“个股趋势”提醒:1. 近30日内无机构对和元生物进行调研。每经头条(nbdtoutiao)——罕见天文大潮来袭!从南到北多个省份突发海水倒灌,有车辆被淹,房屋进水,气象专家:国内外尚未发现明确记载!(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023180315a1e37dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023180315a1e37dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238"],"gpt_icon":0},{"id":"2477306048","title":"和元生物(688238.SH)发前三季业绩,净亏损1.9亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477306048","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477306048?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:57","pubTimestamp":1729677469,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和元生物(688238.SH)发布2024年前三季度报告,报告期内公司实现营业收入1.84亿元,同比增长34.22%;归属于上市公司股东的净亏损1.9亿元;归属于上市公司股东扣除非经常性损益净亏损2亿元;基本每股亏损0.293元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2477844711","title":"和元生物(688238)10月21日主力资金净买入560.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477844711","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477844711?lang=zh_cn&edition=full","pubTime":"2024-10-22 08:20","pubTimestamp":1729556440,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月21日收盘,和元生物报收于5.16元,上涨4.45%,换手率3.78%,成交量17.67万手,成交额9026.28万元。10月21日的资金流向数据方面,主力资金净流入560.37万元,占总成交额6.21%,游资资金净流出589.94万元,占总成交额6.54%,散户资金净流入29.57万元,占总成交额0.33%。近5日资金流向一览见下表:和元生物融资融券信息显示,融资方面,当日融资买入1234.57万元,融资偿还597.83万元,融资净买入636.74万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200006366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2477900561","title":"和元生物大幅上涨 获主力净流入62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477900561","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477900561?lang=zh_cn&edition=full","pubTime":"2024-10-21 13:19","pubTimestamp":1729487965,"startTime":"0","endTime":"0","summary":"10月21日,和元生物股价大幅上涨,截至13点19分,和元生物上涨5.67%,报5.22元/股,成交5457万元,换手率2.32%,振幅5.67%。资金动向截止发稿,和元生物获得主力净流入62万元,其中超大单流出405万元,大单流入468万元。数据显示,该股今日净流入较近5日净流入均值增加213万元。最新财报显示,今年中报,和元生物实现营业收入1.13亿元,同比增长35.00%,净利润为-1.13亿元,同比减少153.01%,基本每股收益为-0.18元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021131956ab6b95f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021131956ab6b95f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2476555424","title":"和元生物大幅上涨 众安保险百万医疗险升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2476555424","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476555424?lang=zh_cn&edition=full","pubTime":"2024-10-18 14:22","pubTimestamp":1729232528,"startTime":"0","endTime":"0","summary":"10月18日,和元生物股价大幅上涨,截至14点22分,和元生物上涨5.27%,报4.99元/股,成交4843万元,换手率2.15%。消息解读2024年,在最新一版《众安在线财产保险股份有限公司个人医疗保险条款》中,众安保险的老牌百万医疗险“尊享e生”就做了升级。更新后的“尊享e生”有4款保险产品可供选择,不仅外购药的清单不做限制,而且对外购药的保额从1万元~300万元不等。资金动向截止发稿,和元生物获得主力净流出384万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018143619ab6b0f38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018143619ab6b0f38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2474087871","title":"和元生物大跌5.04% 获主力净流出757万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474087871","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474087871?lang=zh_cn&edition=full","pubTime":"2024-10-11 09:58","pubTimestamp":1728611937,"startTime":"0","endTime":"0","summary":"10月11日,和元生物股价大幅下跌,截至09点58分,和元生物下跌5.04%,报5.09元/股,成交2229万元,换手率0.92%。资金动向截止发稿,和元生物获得主力净流出757万元,其中超大单流出668万元,大单流出88万元。数据显示,该股今日净流入较近5日净流入均值增加72万元。最新财报显示,今年中报,和元生物实现营业收入1.13亿元,同比增长35.00%,净利润为-1.13亿元,同比减少153.01%,基本每股收益为-0.18元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011110758ab694d6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011110758ab694d6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2474006667","title":"和元生物(688238)10月10日主力资金净卖出818.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474006667","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474006667?lang=zh_cn&edition=full","pubTime":"2024-10-11 08:27","pubTimestamp":1728606444,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月10日收盘,和元生物报收于5.36元,下跌3.94%,换手率3.51%,成交量16.38万手,成交额9062.87万元。10月10日的资金流向数据方面,主力资金净流出818.05万元,占总成交额9.03%,游资资金净流入811.5万元,占总成交额8.95%,散户资金净流入6.54万元,占总成交额0.07%。近5日资金流向一览见下表:和元生物融资融券信息显示,融资方面,当日融资买入1494.85万元,融资偿还782.82万元,融资净买入712.03万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100005946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2474767929","title":"和元生物10月10日主力资金流出827万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2474767929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474767929?lang=zh_cn&edition=full","pubTime":"2024-10-10 15:19","pubTimestamp":1728544745,"startTime":"0","endTime":"0","summary":"10月10日, 和元生物股价跌3.94%,报收5.36元,成交金额9062万元,换手率3.51%,振幅8.78%,量比0.82。和元生物今日主力资金净流出827万元,连续7日净流出,上一交易日主力净流出1757万元,今日环比减少52.93%。近一年数据显示,该股主力连续7日净流出后,次日下跌概率为33.33%,平均跌幅为1.95%。该股近5个交易日上涨22.94%,主力资金累计净流出4149万元;近20日主力资金累计净流出4316万元,其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010153655959cb744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010153655959cb744&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2474265316","title":"和元生物大跌5.48% 融资融券余额实现2连增","url":"https://stock-news.laohu8.com/highlight/detail?id=2474265316","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474265316?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:30","pubTimestamp":1728437401,"startTime":"0","endTime":"0","summary":"10月09日,和元生物股价大幅下跌,截至09点30分,和元生物下跌5.48%,报5.87元/股,成交173万元,换手率0.06%,振幅0.32%。资金动向截止发稿,和元生物获得主力净流出1061万元,其中超大单流出565万元,大单流出495万元。融资融券方面,和元生物10月08日获得融资净买入2058万元,当日该股融资余额为1.80亿元,当较前一日增加12.93%,实现2连增;该股融券余额为10万元,融券余量为1.84万股,比上日减少12.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009121005ab68b2fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009121005ab68b2fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2473581466","title":"和元生物创4个月新高 获融资净买入9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473581466","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473581466?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:30","pubTimestamp":1728351001,"startTime":"0","endTime":"0","summary":"10月08日,和元生物股价大幅上涨,截至09点30分,和元生物上涨19.74%,报6.43元/股,创近4个月新高,成交1442万元,换手率0.48%,振幅0.19%。资金动向截止发稿,和元生物获得主力净流出72万元,其中超大单流入1373万元,大单流出1445万元。融资融券方面,和元生物09月30日获得融资净买入9万元,当日该股融资余额为1.59亿元,当较前一日增加0.06%;该股融券余额为13万元,融券余量为2.10万股,比上日减少65.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008101059ab684287&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008101059ab684287&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-03-22","address":"上海市浦东新区国际医学园区紫萍路908弄19号楼","stockEarnings":[{"period":"1week","weight":0.0271},{"period":"1month","weight":0.2599},{"period":"3month","weight":0.3145},{"period":"6month","weight":0.0557},{"period":"1year","weight":-0.3897},{"period":"ytd","weight":-0.3259}],"companyName":"和元生物技术(上海)股份有限公司","boardCode":"AI0073","perCapita":"37393股","boardName":"研究和试验发展","registeredCapital":"64743万元","compareEarnings":[{"period":"1week","weight":-0.0262},{"period":"1month","weight":0.0558},{"period":"3month","weight":0.1738},{"period":"6month","weight":0.0716},{"period":"1year","weight":0.0999},{"period":"ytd","weight":0.1361}],"survey":" 和元生物技术(上海)股份有限公司是一家聚焦基因治疗领域的生物科技公司,专注于为基因治疗的基础研究提供基因治疗载体研制、基因功能研究等CRO服务,以及为基因药物的研发提供IND-CMC药学研究、临床样品GMP生产等CDMO服务。主要产品有基因治疗CRO、基因治疗CDMO、生物制剂、试剂。","serverTime":1731605077348,"listedPrice":13.23,"stockholders":"12482人(较上一季度增加3.05%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和元生物,688238,和元生物股票,和元生物股票老虎,和元生物股票老虎国际,和元生物行情,和元生物股票行情,和元生物股价,和元生物股市,和元生物股票价格,和元生物股票交易,和元生物股票购买,和元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}